Cargando…
Chronic Myeloid Leukemia Patient’s Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial
Background: The main objective of this study is to gain further insights on how chronic myeloid leukemia (CML) patients involved in an interventional clinical trial with the purpose of reaching treatment free remission (TFR) phase, perceived and experienced TFR failure. TFR failure was defined for t...
Autores principales: | Borghi, Lidia, Galimberti, Sara, Baratè, Claudia, Bonifacio, Massimiliano, Capochiani, Enrico, Cuneo, Antonio, Falzetti, Franca, Iurlo, Alessandra, Lunghi, Francesca, Minotto, Claudia, Orlandi, Ester Maria, Rege-Cambrin, Giovanna, Sica, Simona, Supekar, Sharon, Haenig, Jens, Vegni, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391340/ https://www.ncbi.nlm.nih.gov/pubmed/30842749 http://dx.doi.org/10.3389/fpsyg.2019.00329 |
Ejemplares similares
-
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy
por: Borghi, Lidia, et al.
Publicado: (2021) -
A Prospective Cross-Sectional Study on the Comparison of Ultrasound Assessment vs. Palpation in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy
por: Benedetti, Edoardo, et al.
Publicado: (2022) -
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
por: Breccia, Massimo, et al.
Publicado: (2020) -
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease
por: Benedetti, Edoardo, et al.
Publicado: (2023) -
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study
por: Iurlo, Alessandra, et al.
Publicado: (2022)